Twist Bioscience Corp. (TWST)
140.74
-4.85
(-3.33%)
USD |
NASDAQ |
Aug 24, 16:00
138.00
-2.74
(-1.95%)
After-Hours: 20:00
Twist Bioscience Total Assets (Quarterly) : 672.44M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 672.44M |
| March 31, 2026 | 676.21M |
| December 31, 2025 | 638.08M |
| September 30, 2025 | 641.86M |
| June 30, 2025 | 643.60M |
| March 31, 2025 | 595.62M |
| December 31, 2024 | 608.58M |
| September 30, 2024 | 614.32M |
| June 30, 2024 | 638.12M |
| March 31, 2024 | 702.85M |
| December 31, 2023 | 732.82M |
| September 30, 2023 | 776.40M |
| June 30, 2023 | 810.33M |
| March 31, 2023 | 853.92M |
| December 31, 2022 | 909.97M |
| September 30, 2022 | 961.38M |
| June 30, 2022 | 979.66M |
| March 31, 2022 | 1.022B |
| Date | Value |
|---|---|
| December 31, 2021 | 786.17M |
| September 30, 2021 | 702.10M |
| June 30, 2021 | 725.30M |
| March 31, 2021 | 677.29M |
| December 31, 2020 | 699.57M |
| September 30, 2020 | 398.88M |
| June 30, 2020 | 408.24M |
| March 31, 2020 | 323.87M |
| December 31, 2019 | 192.28M |
| September 30, 2019 | 186.99M |
| June 30, 2019 | 206.80M |
| March 31, 2019 | 140.17M |
| December 31, 2018 | 164.45M |
| September 30, 2018 | 115.79M |
| June 30, 2018 | 122.66M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 85.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.386B |
| Prime Medicine, Inc. | 249.04M |
| Intellia Therapeutics, Inc. | 857.16M |
| 10X Genomics, Inc. | 1.030B |
| Generate Biomedicines, Inc. | 561.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 226.70M |
| Shareholders Equity (Quarterly) | 445.74M |
| Debt to Equity Ratio | 0.21 |
| Current Ratio | 2.672 |
| Net Debt Paydown Yield | -0.04% |